U.K. Office of Health Economics calls for shake-up to reward antibiotic R&D

---

World News -- July 08, 2011

By Kevin Grogan -- [ via FierceBiotech ]


The U.K. Office of Health Economics has called for new incentives for antibiotics R&D in order to entice companies to focus on the growing superbug threat.  ...

http://www.pharmatimes.com/Article/11-07-08/Calls_for_shake-up_to_reward_antibiotic_R_D.aspx

http://www.ohe.org

-----------


Dateline -- San Diego, Calif.:  10 July 2011 -- 6:45 PM

Posted by:

David A. Palella
Founder
BIOSCIENCE VENTURES Inc.

San Diego, California
cell: 619-787-5767
email:  dpalella@gmail.com
http://www.linkedin.com/in/davidpalella

web site:  http://www.BSVpartners.com

blog: http://biobizdev.blogspot.com


& Group Founder:

Infectious Disease R&D and Business Network
http://www.linkedin.com/e/-ubgx8c-godydbie-43/vgh/3937807/

Japan Biotech / Biopharma Partnering Forum
http://www.linkedin.com/e/vgh/2857975/

Biotech / Pharma Business Development, Licensing & Dealmaking
http://www.linkedin.com/e/-ubgx8c-gp40f4dt-22/vgh/3964633/


& Co-founder:

Stem Cells & Regenerative Medicine
http://www.linkedin.com/e/vgh/3921448

---------